Efficacy of Animal-assisted Therapy in Patients With Borderline Personality Disorder and Addictions.
1 other identifier
interventional
200
0 countries
N/A
Brief Summary
Animal-assisted therapy (AAT) is a complementary intervention of therapy that has shown positive results in the treatment of various pathologies. This study assesses the viability of the implementation and the effectiveness of an AAT program in patients diagnosed with borderline personality disorder and substance abuse disorder. Our hypotheses are that participation in the TAA program will reduce negative symptoms, improve the quality of life of people with dual pathology, whose mental illness is schizophrenia, and increase adherence to treatment for people with dual pathology, whose mental disorder it's schizophrenia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2022
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 30, 2021
CompletedFirst Posted
Study publicly available on registry
November 10, 2021
CompletedStudy Start
First participant enrolled
April 30, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2025
CompletedNovember 10, 2021
October 1, 2021
3 years
October 30, 2021
October 30, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
The Life Skills Profile questionnaire (LSP)
This questionnaire evaluates aspects of functioning that affect daily activities and the adaptation of people with mental illnesses in the community. It contains 39 items that are grouped into self-care, social-interpersonal behaviour, communication-social contact, non-personal social behavior and autonomous life
Change from Life Skills at 3-6-9 months (12 minutes)
Barrat impulsiveness scale (BIS-11)
This instrument is composed of 30 items distributed into three sub-scales: nonplanning, motor and attentional. The total impulsiveness score was also obtained
Change from impulsiveness at 3-6-9 months (12 minutes)
Calgary Depresión Scale for Schizophrenia (CDSS)
The questionnaire is a structured instrument, administered by a clinician in a hetero-applied way for the adult population, with an approximate administration time of between 10 and 30 minutes, and covers the therapeutic area related to the symptoms of depressive disorders.
Change from Depresión at 3-6-9 months (12 minutes)
Rosenberg Self-Esteem Scale
The questionnaire consists of 10 statements of the feelings that the person has about himself. Five of the statements are addressed positively (items 1, 2, 4, 6 and 7) and 5 negatively (items 3, 5, 8, 9 and 10).
Change from self-esteem at 3-6-9 months (12 minutes)
Positive and negative symptom scale (PANSS)
It is a semi-structured and hetero-applied questionnaire for the adult population. The application time is between 30-60 minutes and evaluates the positive and negative symptoms of schizophrenia and other psychotic disorders
Change from Positive and negative symptom at 3-6-9 months (12 minutes)
Study Arms (2)
Experimental group (EG)
EXPERIMENTALReceive animal-assisted therapy and usual treatment (ATT)
Control group
ACTIVE COMPARATORReceive usual treatment
Interventions
The activity program consists of 10 sessions with a duration of about 60 minutes. During the 10 sessions the animal is presented, in this case a dog. They caress it, dress it, educate it ...
Eligibility Criteria
You may qualify if:
- Meeting DSM-5 criteria for substance abuse disorder and the presence of borderline personality disorder.
- Voluntary participant in the study and having signed the informed consent
You may not qualify if:
- Patients whose functioning could be altered by factors not specifically related to addictive pathology or mental disorder (severe cognitive impairment, intellectual deficiency or language barrier)
- Animal-specific phobia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Miguel Monfort Montolio, member of the TXP research group at Cardenal Herrera University
Study Record Dates
First Submitted
October 30, 2021
First Posted
November 10, 2021
Study Start
April 30, 2022
Primary Completion
April 30, 2025
Study Completion
April 30, 2025
Last Updated
November 10, 2021
Record last verified: 2021-10